Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;16(1):51-56.

Trans dermal estrogen (oestrogel) for endometrial preparation in freeze embryo transfer cycle: An RCT

Ensieh Shahrokh Tehraninejad  1 , Roya Kabodmehri  1 , Batol Hosein Rashidi  1 , Mina Jafarabadi  1 , Fateme Keikha  1 , Masomeh Masomi  1 , Fedieh Hagholahi  1
Affiliations

Trans dermal estrogen (oestrogel) for endometrial preparation in freeze embryo transfer cycle: An RCT

Ensieh Shahrokh Tehraninejad et al. Int J Reprod Biomed. 2018 Jan.

Abstract

Background: Estrogen and progesterone are two crucial factors for endometrial preparation in frozen embryo transfer (FET) cycles. Studies assessing different forms of estradiol in FET have published already but literature lacks enough surveys on transdermal estrogen application in reproductive medicine.

Objective: To investigate the effects of trans dermal estrogen (Oestrogel) on pregnancy rates in patients that candidate for FET cycle.

Materials and methods: In this randomized clinical trial, 100 women undergoing FET cycles referred to Imam Khomeeini Hospital were enrolled in two groups, randomly. Group I received 8 mg/day estradiol valerate (E2 tablet) orally and group II were treated with 6 mg/day transdermal oestrogel gel after suppression with gonadotropin releasing hormone agonist. In both groups medication were started in the first day of menstruation cycle and continued until endometrial thickness reached 8 mm. Pregnancy rates (chemical, clinical, and ongoing), abortion rate, live birth rate, and frequency of complications were compared between two groups.

Results: Chemical and clinical pregnancy rates were not significantly different between two groups (p=0.384). The abortion rate was significantly lower in group II than group I (p=0.035). Ongoing pregnancy and the live birth rates were significantly higher in group II (p=0.035). The rate of complication was not different in two groups.

Conclusion: Oestrogel seems to enhance ongoing pregnancy and live birth rates in comparison to estradiol valerate tablet.

Keywords: Estradiol valerate GnRH analogue; FET cycle; Transdermal estrogen.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure 1
Figure 1
Consort flow chart.
See this image and copyright information in PMC

References

    1. Gardner DK, Weissman A, Howles CM, Shoham Z. Textbook of Assisted Reproductive Techniques. 4th Ed. Clinical Perspectives, CRC press; 2012.
    1. Nygren KG, Sullivan E, Zegers-Hochschild F, Mansour R, Ishihara O, Adamson GD, et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003. Fertil Steril. 2011;95:2209–2222. - PubMed
    1. Muasher SJ, Kruithoff C, Simonetti S, Oehninger S, Acosta AA, Jones GS. Controlled preparation of the endometrium with exogenous steroids for the transfer of frozen-thawed pre-embryos in patients with anovulatory or irregular cycles. Hum Reprod. 1991;6:443–445. - PubMed
    1. Devroey P, Pados G. Preparation of endometrium for egg donation. Hum Reprod Update. 1998;4:856–861. - PubMed
    1. Devroey P, Wisanto A, Camus M, Van Waesberghe L, Bourgain C, Liebaers I, et al. Oocyte donation in patients without ovarian function. Hum Reprod. 1988;3:699–704. - PubMed

LinkOut - more resources